Literature DB >> 17174984

The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model.

El Mustapha Bahassi1, C Gail Penner, Susan B Robbins, Elisia Tichy, Estrella Feliciano, Moying Yin, Li Liang, Li Deng, Jay A Tischfield, Peter J Stambrook.   

Abstract

Allelic variants of CHEK2 contribute to an elevated risk for human breast cancer and possibly other cancer types. In particular, the CHEK2*1100delC polymorphic variant has been identified as a low-penetrance breast cancer susceptibility allele in breast cancer families with wild type BRCA1 and BRCA2. To better understand the molecular basis by which this allele increases risk for disease, we have generated a mouse in which the wild type CHEK2 (Chk2 in mouse) allele has been replaced with the 1100delC variant. Mouse embryo fibroblasts (MEFs) derived from these mice have an altered cell cycle profile in which a far greater proportion of cells are in S-phase and in G2 (4N) compared with wild type cells. The mutant cells show signs of spontaneous genomic instability as indicated by polyploidy and an increase in DNA double strand breaks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174984     DOI: 10.1016/j.mrfmmm.2006.11.025

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  13 in total

1.  CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer.

Authors:  Petra E A Huijts; Antoinette Hollestelle; Brunilda Balliu; Jeanine J Houwing-Duistermaat; Caro M Meijers; Jannet C Blom; Bahar Ozturk; Elly M M Krol-Warmerdam; Juul Wijnen; Els M J J Berns; John W M Martens; Caroline Seynaeve; Lambertus A Kiemeney; Henricus F van der Heijden; Rob A E M Tollenaar; Peter Devilee; Christi J van Asperen
Journal:  Eur J Hum Genet       Date:  2013-05-08       Impact factor: 4.246

2.  Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice.

Authors:  Sara E Meyer; Belinda E Peace; El Mustapha Bahassi; Gina M Kavanaugh; Purnima K Wagh; Susan B Robbins; Moying Yin; Susanne I Wells; Glendon M Zinser; Peter J Stambrook; Susan E Waltz
Journal:  Cancer Lett       Date:  2010-10-28       Impact factor: 8.679

3.  Map making in the 21st century: charting breast cancer susceptibility pathways in rodent models.

Authors:  Anneke C Blackburn; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-08       Impact factor: 2.673

Review 4.  Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease.

Authors:  Zachary D Nagel; Bevin P Engelward; David J Brenner; Thomas J Begley; Robert W Sobol; Jason H Bielas; Peter J Stambrook; Qingyi Wei; Jennifer J Hu; Mary Beth Terry; Caroline Dilworth; Kimberly A McAllister; Les Reinlib; Leroy Worth; Daniel T Shaughnessy
Journal:  Mutat Res       Date:  2017-04-06       Impact factor: 2.433

5.  Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.

Authors:  Daphne W Bell; Sang H Kim; Andrew K Godwin; Taryn A Schiripo; Patricia L Harris; Sara M Haserlat; Doke C R Wahrer; Christopher A Haiman; Mary B Daly; Kristin B Niendorf; Matthew R Smith; Dennis C Sgroi; Judy E Garber; Olufunmilayo I Olopade; Loic Le Marchand; Brian E Henderson; David Altshuler; Daniel A Haber; Matthew L Freedman
Journal:  Int J Cancer       Date:  2007-12-15       Impact factor: 7.396

6.  Chk2 suppresses the oncogenic potential of DNA replication-associated DNA damage.

Authors:  Travis H Stracker; Suzana S Couto; Carlos Cordon-Cardo; Tulio Matos; John H J Petrini
Journal:  Mol Cell       Date:  2008-07-11       Impact factor: 17.970

Review 7.  Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response.

Authors:  Travis H Stracker; Takehiko Usui; John H J Petrini
Journal:  DNA Repair (Amst)       Date:  2009-05-26

8.  Mice with the CHEK2*1100delC SNP are predisposed to cancer with a strong gender bias.

Authors:  El Mustapha Bahassi; Susan B Robbins; Moying Yin; Gregory P Boivin; Raoul Kuiper; Harry van Steeg; Peter J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-21       Impact factor: 11.205

Review 9.  p53 polymorphisms: cancer implications.

Authors:  Catherine Whibley; Paul D P Pharoah; Monica Hollstein
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

10.  The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus.

Authors:  Zdenek Andrysik; William Z Bernstein; Li Deng; David L Myer; Ya-Qin Li; Jay A Tischfield; Peter J Stambrook; El Mustapha Bahassi
Journal:  Nucleic Acids Res       Date:  2010-01-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.